Breast cancer cell invasion into a three dimensional tumor-stroma microenvironment

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Truong, Danh ^a   Puleo, Julieann ^b   Llave, Alison ^a   Mouneimne, Ghassan ^b   Kamm, Roger D ^c   Nikkhah, Mehdi ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84989832860     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34094     Document Type: Article

References (71)

1. Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J Clin 64, 9-29, doi: 10.3322/caac.21208 (2014).
2. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674, doi: 10.1016/j.cell.2011.02.013 (2011).
3. Gupta, G. P. & Massague, J. Cancer metastasis: building a framework. Cell 127, 679-695, doi: 10.1016/j.cell.2006.11.001 (2006).
4. Mao, Y., Keller, E. T., Garfield, D. H., Shen, K. & Wang, J. Stromal cells in tumor microenvironment and breast cancer. Cancer Metastasis Rev 32, 303-315, doi: 10.1007/s10555-012-9415-3 (2013).
5. Conklin, M. W. & Keely, P. J. Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkers. Cell Adh Migr 6, 249-260, doi: 10.4161/cam.20567 (2012).
6. Khamis, Z. I., Sahab, Z. J. & Sang, Q. X. Active roles of tumor stroma in breast cancer metastasis. Int J Breast Cancer 2012, 574025, doi: 10.1155/2012/574025 (2012).
7. Thoma, C. R., Zimmermann, M., Agarkova, I., Kelm, J. M. & Krek, W. 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev 69-70, 29-41, doi: 10.1016/j.addr.2014.03.001 (2014).
8. Lee, J. M., et al. A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. Laboratory Investigation; a Journal of Technical Methods and Pathology 93, 528-542, doi: 10.1038/labinvest.2013.41 (2013).
9. McMillin, D. W., Negri, J. M. & Mitsiades, C. S. The role of tumour-stromal interactions in modifying drug response: challenges and opportunities. Nat Rev Drug Discov 12, 217-228, doi: 10.1038/nrd3870 (2013).
10. Paraiso, K. H. T. & Smalley, K. S. M. Fibroblast-mediated drug resistance in cancer. Biochemical Pharmacology 85, 1033-1041, doi: 10.1016/j.bcp.2013.01.018 (2013).
11. dit Faute, M. A., et al. Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant. Clin Exp Metastasis 19, 161-168 (2002).
12. Knowlton, S., Onal, S., Yu, C. H., Zhao, J. J. & Tasoglu, S. Bioprinting for cancer research. Trends in biotechnology 33, 504-513, doi: 10.1016/j.tibtech.2015.06.007 (2015).
13. Hagemann, T., et al. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 25, 1543-1549, doi: 10.1093/carcin/bgh146 (2004).
14. Goswami, S., et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 65, 5278-5283, doi: 10.1158/0008-5472.CAN-04-1853 (2005).
15. Dudu, V., Able, R. A. Jr., Rotari, V., Kong, Q. & Vazquez, M. Role of Epidermal Growth Factor-Triggered PI3K/Akt Signaling in the Migration of Medulloblastoma-Derived Cells. Cell Mol Bioeng 5, 502-413 (2012).
16. Meng, Q., Xia, C., Fang, J., Rojanasakul, Y. & Jiang, B. H. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cell Signal 18, 2262-2271, doi: 10.1016/j.cellsig.2006.05.019 (2006).
17. Price, J. T., Tiganis, T., Agarwal, A., Djakiew, D. & Thompson, E. W. Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3 -kinase and phospholipase C-dependent mechanism. Cancer Research 59, 5475-5478 (1999).
18. Wyckoff, J., et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64, 7022-7029, doi: 10.1158/0008-5472.CAN-04-1449 (2004).
19. Provenzano, P. P., et al. Collagen density promotes mammary tumor initiation and progression. BMC Med 6, 11, doi: 10.1186/1741- 7015-6-11 (2008).
20. Provenzano, P. P., et al. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 4, 38, doi: 10.1186/1741-7015-4-38 (2006).
21. Shields, J. D., et al. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 11, 526-538, doi: 10.1016/j.ccr.2007.04.020 (2007).
22. Pinner, S. & Sahai, E. Imaging amoeboid cancer cell motility in vivo. J Microsc-Oxford 231, 441-445, doi: 10.1111/j.1365-2818.2008.02056.x (2008).
23. Wyckoff, J. B., et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 67, 2649-2656, doi: 10.1158/0008-5472.CAN-06-1823 (2007).
24. Patsialou, A., et al. Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colonystimulating factor-1 receptor. Cancer Res 69, 9498-9506, doi: 10.1158/0008-5472.CAN-09-1868 (2009).
25. Wang, S. J., Saadi, W., Lin, F., Minh-Canh Nguyen, C. & Li Jeon, N. Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis. Exp Cell Res 300, 180-189, doi: 10.1016/j.yexcr.2004.06.030 (2004).
26. Saadi, W., Wang, S. J., Lin, F. & Jeon, N. L. A parallel-gradient microfluidic chamber for quantitative analysis of breast cancer cell chemotaxis. Biomed Microdevices 8, 109-118, doi: 10.1007/s10544-006-7706-6 (2006).
27. Yamada, K. M. & Cukierman, E. Modeling tissue morphogenesis and cancer in 3D. Cell 130, 601-610, doi: 10.1016/j.cell.2007.08.006 (2007).
28. Sung, K. E. & Beebe, D. J. Microfluidic 3D models of cancer. Adv Drug Deliv Rev 79-80, 68-78, doi: 10.1016/j.addr.2014.07.002 (2014).
29. Zervantonakis, I., et al. Concentration gradients in microfluidic 3D matrix cell culture systems. International Journal of Micro-Nano Scale Transport 1, 27-36, doi: 10.1260/1759-3093.1.1.27 (2010).
30. Sung, K. E., et al. Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects. Integr Biol (Camb) 3, 439-450, doi: 10.1039/c0ib00063a (2011).
31. Kim, B. J., et al. Cooperative roles of SDF-1alpha and EGF gradients on tumor cell migration revealed by a robust 3D microfluidic model. PLoS One 8, e68422, doi: 10.1371/journal.pone.0068422 (2013).
32. Haessler, U., Kalinin, Y., Swartz, M. A. & Wu, M. An agarose-based microfluidic platform with a gradient buffer for 3D chemotaxis studies. Biomed Microdevices 11, 827-835, doi: 10.1007/s10544-009-9299-3 (2009).
33. Zervantonakis, I. K., et al. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc Natl Acad Sci USA 109, 13515-13520, doi: 10.1073/pnas.1210182109 (2012).
34. Bersini, S., et al. A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone. Biomaterials 35, 2454-2461, doi: 10.1016/j.biomaterials.2013.11.050 (2014).
35. Jeon, J. S., et al. Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation. Proc Natl Acad Sci USA 112, 214-219, doi: 10.1073/pnas.1417115112 (2015).
36. Chung, S., et al. Cell migration into scaffolds under co-culture conditions in a microfluidic platform. Lab Chip 9, 269-275, doi: 10.1039/b807585a (2009).
37. Sung, K. E., et al. Understanding the impact of 2D and 3D fibroblast cultures on in vitro breast cancer models. PLoS One 8, e76373, doi: 10.1371/journal.pone.0076373 (2013).
38. Weigelt, B., Ghajar, C. M. & Bissell, M. J. The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer. Adv Drug Deliv Rev 69-70, 42-51, doi: 10.1016/j.addr.2014.01.001 (2014).
39. Bissell, M. J., Radisky, D. C., Rizki, A., Weaver, V. M. & Petersen, O. W. The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 70, 537-546, doi: 10.1046/j.1432-0436.2002.700907.x (2002).
40. Nelson, C. M. & Bissell, M. J. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Biol 15, 342-352, doi: 10.1016/j.semcancer.2005.05.001 (2005).
41. Huang, C. P., et al. Engineering microscale cellular niches for three-dimensional multicellular co-cultures. Lab Chip 9, 1740-1748, doi: 10.1039/b818401a (2009).
42. Farahat, W. A., et al. Ensemble analysis of angiogenic growth in three-dimensional microfluidic cell cultures. PLoS One 7, e37333, doi: 10.1371/journal.pone.0037333 (2012).
43. Ma, H., Liu, T., Qin, J. & Lin, B. Characterization of the interaction between fibroblasts and tumor cells on a microfluidic co-culture device. Electrophoresis 31, 1599-1605, doi: 10.1002/elps.200900776 (2010).
44. Wang, Q., Villeneuve, G. & Wang, Z. X. Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation. Embo Rep 6, 942-948, doi: 10.1038/sj.embor.7400491 (2005).
45. Mutch, L. J., Howden, J. D., Jenner, E. P., Poulter, N. S. & Rappoport, J. Z. Polarised clathrin-mediated endocytosis of EGFR during chemotactic invasion. Traffic 15, 648-664 (2014).
46. Nikkhah, M., Strobl, J. S., Peddi, B. & Agah, M. Cytoskeletal role in differential adhesion patterns of normal fibroblasts and breast cancer cells inside silicon microenvironments. Biomed Microdevices 11, 585-595, doi: 10.1007/s10544-008-9268-2 (2009).
47. Nikkhah, M., et al. MCF10A and MDA-MB-231 human breast basal epithelial cell co-culture in silicon micro-arrays. Biomaterials 32, 7625-7632, doi: 10.1016/j.biomaterials.2011.06.041 (2011).
48. Nikkhah, M., Strobl, J. S., De Vita, R. & Agah, M. The cytoskeletal organization of breast carcinoma and fibroblast cells inside three dimensional (3-D) isotropic silicon microstructures. Biomaterials 31, 4552-4561, doi: 10.1016/j.biomaterials.2010.02.034 (2010).
49. Strobl, J. S., Nikkhah, M. & Agah, M. Actions of the anti-cancer drug suberoylanilide hydroxamic acid (SAHA) on human breast cancer cytoarchitecture in silicon microstructures. Biomaterials 31, 7043-7050, doi: 10.1016/j.biomaterials.2010.05.023 (2010).
50. Peela, N., et al. A three dimensional micropatterned tumor model for breast cancer cell migration studies. Biomaterials 81, 72-83, doi: 10.1016/j.biomaterials.2015.11.039 (2015).
51. Even-Ram, S. & Yamada, K. M. Cell migration in 3D matrix. Curr Opin Cell Biol 17, 524-532, doi: 10.1016/j.ceb.2005.08.015 (2005).
52. Smalley, K. S., Lioni, M. & Herlyn, M. Life isnt flat: taking cancer biology to the next dimension. In vitro cellular & developmental biology. Animal 42, 242-247, doi: 10.1290/0604027.1 (2006).
53. Mosadegh, B., Saadi, W., Wang, S. J. & Jeon, N. L. Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients. Biotechnol Bioeng 100, 1205-1213, doi: 10.1002/bit.21851 (2008).
54. Paszek, M. J., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241-254, doi: 10.1016/j.ccr.2005.08.010 (2005).
55. Campbell, L. L. & Polyak, K. Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle 6, 2332-2338 (2007).
56. Hughes-Alford, S. K. & Lauffenburger, D. A. Quantitative analysis of gradient sensing: towards building predictive models of chemotaxis in cancer. Curr Opin Cell Biol 24, 284-291, doi: 10.1016/j.ceb.2012.01.001 (2012).
57. Ichinose, J., Murata, M., Yanagida, T. & Sako, Y. EGF signalling amplification induced by dynamic clustering of EGFR. Biochem Biophys Res Commun 324, 1143-1149, doi: 10.1016/j.bbrc.2004.09.173 (2004).
58. Schulte, A., et al. Glioblastoma Stem-like Cell Lines with Either Maintenance or Loss of High-Level EGFR Amplification, Generated via Modulation of Ligand Concentration. Clinical Cancer Research 18, 1901-1913, doi: 10.1158/1078-0432.Ccr-11-3084 (2012).
59. Friedl, P. & Wolf, K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3, 362-374, doi: 10.1038/nrc1075 (2003).
60. Lammermann, T., et al. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 453, 51-55, doi: 10.1038/nature06887 (2008).
61. Fraley, S. I., et al. A distinctive role for focal adhesion proteins in three-dimensional cell motility. Nat Cell Biol 12, 598-604, doi: 10.1038/ncb2062 (2010).
62. Gaggioli, C., et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 9, 1392-1400, doi: 10.1038/ncb1658 (2007).
63. Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nat Rev Cancer 6, 392-401, doi: 10.1038/nrc1877 (2006).
64. Orimo, A., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348, doi: 10.1016/j.cell.2005.02.034 (2005).
65. Loessner, D., et al. Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 31, 8494-8506, doi: 10.1016/j.biomaterials.2010.07.064 (2010).
66. Kothapalli, C. R. & Honarmandi, P. Theoretical and experimental quantification of the role of diffusive chemogradients on neuritogenesis within three-dimensional collagen scaffolds. Acta Biomater 10, 3664-3674, doi: 10.1016/j.actbio.2014.05.009 (2014).
67. Wang, C., Lu, H. & Schwartz, M. A. A novel in vitro flow system for changing flow direction on endothelial cells. J Biomech 45, 1212-1218, doi: 10.1016/j.jbiomech.2012.01.045 (2012).
68. Stylianopoulos, T., Diop-Frimpong, B., Munn, L. L. & Jain, R. K. Diffusion anisotropy in collagen gels and tumors: the effect of fiber network orientation. Biophys J 99, 3119-3128, doi: 10.1016/j.bpj.2010.08.065 (2010).
69. Sabeh, F., Shimizu-Hirota, R. & Weiss, S. J. Protease-dependent versus-independent cancer cell invasion programs: threedimensional amoeboid movement revisited. J Cell Biol 185, 11-19, doi: 10.1083/jcb.200807195 (2009).
70. Guo, Y., et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. Journal of magnetic resonance imaging : JMRI 16, 172-178, doi: 10.1002/jmri.10140 (2002).
71. Lyng, H., Haraldseth, O. & Rofstad, E. K. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magnetic resonance in medicine 43, 828-836 (2000).